Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Dr. Norm's has shown notable progress in the California market, particularly in the Capsules category. Over the last four months of 2025, the brand's ranking has improved steadily, climbing from 14th position in September to 8th by December. This upward trajectory suggests a growing consumer preference or a successful marketing strategy that has bolstered its position. The increase in sales from $10,859 in September to $102,431 in December further underscores this positive trend. In contrast, the Edible category has seen a more fluctuating performance, with Dr. Norm's maintaining a mid-tier position, ranking between 15th and 17th place from October to December. This indicates a stable yet less dominant presence in the Edible market compared to their Capsules category success.
The absence of Dr. Norm's from the top 30 rankings in any other state or category highlights a potential area for growth or a focus on strengthening their presence in California. While the Capsules category's performance is commendable, the brand's consistent mid-range ranking in Edibles might suggest a need for strategic adjustments to enhance competitiveness. The data reveals that while there is significant room for improvement in some areas, Dr. Norm's has successfully carved out a niche within the Capsules market in California, which could serve as a foundation for expanding their influence both within and beyond the state.
Competitive Landscape
In the competitive landscape of the California edible market, Dr. Norm's experienced a fluctuating rank from September to December 2025, indicating a dynamic competitive environment. Initially ranked 16th in September, Dr. Norm's improved to 15th in October, only to slip back to 16th in November and further to 17th in December. This downward trend in rank contrasts with the performance of Kiva Chocolate and Big Pete's Treats, both of which showed consistent improvements, with Kiva rising from 17th to 15th and Big Pete's Treats from 19th to 16th by December. Meanwhile, Clsics also experienced a decline, dropping from 15th to 18th, suggesting a competitive reshuffle among these brands. Despite Dr. Norm's sales peaking in October, the subsequent decline in sales and rank indicates a need for strategic adjustments to regain its competitive edge in this rapidly evolving market.

Notable Products
In December 2025, Dr. Norm's top-performing product was the Wicked Watermelon Hash Gummy (100mg), maintaining its consistent rank of 1st place since September, despite a slight decrease in sales to 3049 units. The Fruity Pebbles Rice Crispy Bar (100mg) climbed to the 2nd position, showing a notable increase in sales compared to previous months. Indica Max Tablets 20-Pack (1000mg) entered the rankings at 3rd place, marking its first appearance in the dataset. Sleepwell THC/CBD/CBG/CBN Sweet Dreams Distillate Disposable (1g) improved its rank to 4th place from 5th in November, while the Key Lime High Max Gummy (100mg) dropped to 5th place from its consistent 2nd position in prior months. This shift in rankings reflects dynamic changes in consumer preferences within Dr. Norm's product lineup.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







